The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response

Wendy Niedelman, Daniel Gold, Emily E. Rosowski, Joris K. Sprokholt, Daniel Lim, Ailan Farid Arenas, Mariane B. Melo, Eric Spooner, Michael B. Yaffe, Jeroen Saeij

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

The obligate intracellular parasite Toxoplasma gondii secretes effector proteins into the host cell that manipulate the immune response allowing it to establish a chronic infection. Crosses between the types I, II and III strains, which are prevalent in North America and Europe, have identified several secreted effectors that determine strain differences in mouse virulence. The polymorphic rhoptry protein kinase ROP18 was recently shown to determine the difference in virulence between type I and III strains by phosphorylating and inactivating the interferon-γ (IFNγ)-induced immunity-related GTPases (IRGs) that promote killing by disrupting the parasitophorous vacuole membrane (PVM) in murine cells. The polymorphic pseudokinase ROP5 determines strain differences in virulence through an unknown mechanism. Here we report that ROP18 can only inhibit accumulation of the IRGs on the PVM of strains that also express virulent ROP5 alleles. In contrast, specific ROP5 alleles can reduce IRG coating even in the absence of ROP18 expression and can directly interact with one or more IRGs. We further show that the allelic combination of ROP18 and ROP5 also determines IRG evasion and virulence of strains belonging to other lineages besides types I, II and III. However, neither ROP18 nor ROP5 markedly affect survival in IFNγ-activated human cells, which lack the multitude of IRGs present in murine cells. These findings suggest that ROP18 and ROP5 have specifically evolved to block the IRGs and are unlikely to have effects in species that do not have the IRG system, such as humans.

Original languageEnglish (US)
Article numbere1002784
JournalPLoS Pathogens
Volume8
Issue number6
DOIs
StatePublished - Jun 2012
Externally publishedYes

Fingerprint

GTP Phosphohydrolases
Toxoplasma
Immunity
Virulence
Proteins
Vacuoles
Interferons
Alleles
Membranes
human IFNG protein
North America
Protein Kinases
Parasites
Survival
Infection

ASJC Scopus subject areas

  • Microbiology
  • Parasitology
  • Virology
  • Immunology
  • Genetics
  • Molecular Biology

Cite this

The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. / Niedelman, Wendy; Gold, Daniel; Rosowski, Emily E.; Sprokholt, Joris K.; Lim, Daniel; Arenas, Ailan Farid; Melo, Mariane B.; Spooner, Eric; Yaffe, Michael B.; Saeij, Jeroen.

In: PLoS Pathogens, Vol. 8, No. 6, e1002784, 06.2012.

Research output: Contribution to journalArticle

Niedelman, Wendy ; Gold, Daniel ; Rosowski, Emily E. ; Sprokholt, Joris K. ; Lim, Daniel ; Arenas, Ailan Farid ; Melo, Mariane B. ; Spooner, Eric ; Yaffe, Michael B. ; Saeij, Jeroen. / The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. In: PLoS Pathogens. 2012 ; Vol. 8, No. 6.
@article{166e2c7323784fdaa3e96eec0d14f342,
title = "The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response",
abstract = "The obligate intracellular parasite Toxoplasma gondii secretes effector proteins into the host cell that manipulate the immune response allowing it to establish a chronic infection. Crosses between the types I, II and III strains, which are prevalent in North America and Europe, have identified several secreted effectors that determine strain differences in mouse virulence. The polymorphic rhoptry protein kinase ROP18 was recently shown to determine the difference in virulence between type I and III strains by phosphorylating and inactivating the interferon-γ (IFNγ)-induced immunity-related GTPases (IRGs) that promote killing by disrupting the parasitophorous vacuole membrane (PVM) in murine cells. The polymorphic pseudokinase ROP5 determines strain differences in virulence through an unknown mechanism. Here we report that ROP18 can only inhibit accumulation of the IRGs on the PVM of strains that also express virulent ROP5 alleles. In contrast, specific ROP5 alleles can reduce IRG coating even in the absence of ROP18 expression and can directly interact with one or more IRGs. We further show that the allelic combination of ROP18 and ROP5 also determines IRG evasion and virulence of strains belonging to other lineages besides types I, II and III. However, neither ROP18 nor ROP5 markedly affect survival in IFNγ-activated human cells, which lack the multitude of IRGs present in murine cells. These findings suggest that ROP18 and ROP5 have specifically evolved to block the IRGs and are unlikely to have effects in species that do not have the IRG system, such as humans.",
author = "Wendy Niedelman and Daniel Gold and Rosowski, {Emily E.} and Sprokholt, {Joris K.} and Daniel Lim and Arenas, {Ailan Farid} and Melo, {Mariane B.} and Eric Spooner and Yaffe, {Michael B.} and Jeroen Saeij",
year = "2012",
month = "6",
doi = "10.1371/journal.ppat.1002784",
language = "English (US)",
volume = "8",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response

AU - Niedelman, Wendy

AU - Gold, Daniel

AU - Rosowski, Emily E.

AU - Sprokholt, Joris K.

AU - Lim, Daniel

AU - Arenas, Ailan Farid

AU - Melo, Mariane B.

AU - Spooner, Eric

AU - Yaffe, Michael B.

AU - Saeij, Jeroen

PY - 2012/6

Y1 - 2012/6

N2 - The obligate intracellular parasite Toxoplasma gondii secretes effector proteins into the host cell that manipulate the immune response allowing it to establish a chronic infection. Crosses between the types I, II and III strains, which are prevalent in North America and Europe, have identified several secreted effectors that determine strain differences in mouse virulence. The polymorphic rhoptry protein kinase ROP18 was recently shown to determine the difference in virulence between type I and III strains by phosphorylating and inactivating the interferon-γ (IFNγ)-induced immunity-related GTPases (IRGs) that promote killing by disrupting the parasitophorous vacuole membrane (PVM) in murine cells. The polymorphic pseudokinase ROP5 determines strain differences in virulence through an unknown mechanism. Here we report that ROP18 can only inhibit accumulation of the IRGs on the PVM of strains that also express virulent ROP5 alleles. In contrast, specific ROP5 alleles can reduce IRG coating even in the absence of ROP18 expression and can directly interact with one or more IRGs. We further show that the allelic combination of ROP18 and ROP5 also determines IRG evasion and virulence of strains belonging to other lineages besides types I, II and III. However, neither ROP18 nor ROP5 markedly affect survival in IFNγ-activated human cells, which lack the multitude of IRGs present in murine cells. These findings suggest that ROP18 and ROP5 have specifically evolved to block the IRGs and are unlikely to have effects in species that do not have the IRG system, such as humans.

AB - The obligate intracellular parasite Toxoplasma gondii secretes effector proteins into the host cell that manipulate the immune response allowing it to establish a chronic infection. Crosses between the types I, II and III strains, which are prevalent in North America and Europe, have identified several secreted effectors that determine strain differences in mouse virulence. The polymorphic rhoptry protein kinase ROP18 was recently shown to determine the difference in virulence between type I and III strains by phosphorylating and inactivating the interferon-γ (IFNγ)-induced immunity-related GTPases (IRGs) that promote killing by disrupting the parasitophorous vacuole membrane (PVM) in murine cells. The polymorphic pseudokinase ROP5 determines strain differences in virulence through an unknown mechanism. Here we report that ROP18 can only inhibit accumulation of the IRGs on the PVM of strains that also express virulent ROP5 alleles. In contrast, specific ROP5 alleles can reduce IRG coating even in the absence of ROP18 expression and can directly interact with one or more IRGs. We further show that the allelic combination of ROP18 and ROP5 also determines IRG evasion and virulence of strains belonging to other lineages besides types I, II and III. However, neither ROP18 nor ROP5 markedly affect survival in IFNγ-activated human cells, which lack the multitude of IRGs present in murine cells. These findings suggest that ROP18 and ROP5 have specifically evolved to block the IRGs and are unlikely to have effects in species that do not have the IRG system, such as humans.

UR - http://www.scopus.com/inward/record.url?scp=84864075588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864075588&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1002784

DO - 10.1371/journal.ppat.1002784

M3 - Article

C2 - 22761577

AN - SCOPUS:84864075588

VL - 8

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 6

M1 - e1002784

ER -